U.S. Markets open in 15 hrs, 19 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,430.21 | 12.78 | 0.11% |
| NASDAQ | 2,380.38 | -8.70 | -0.36% |
| S&P 500 | 1,277.72 | 3.18 | 0.25% |
| Day Low 11:13 AM EDT | 1.927 | |
|---|---|---|
| Day High 03:27 PM EDT | 2.03 |
|
| Range | 0.10 | |
| Volume | 2,915 | |
| 30-Day Avg. Vol. | 29,000 |
|
| Difference | -89.95% | |
| Market Cap. | 99.22 M | |
| Change | 4.39 M | |
| Shares Out. | 48.47 M | |
| Percent Traded | 0.01% | |
| Revenue | 482,000 | |
| Earnings | -11.57 M | |
| EPS (TTM) | -0.40 |
| 52-Wk Low 7/2/08 | 1.67 | |
|---|---|---|
| 52-Wk High 9/11/07 | 6.85 |
|
| Range | 5.18 | |
| Prev. Close 8/20/08 | 1.94 | |
| Today's Open | 1.927 | |
| Change | -0.67% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.2927 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -5.00 |
Corcept Therapeutics wants to help people who are beyond blue. The biotechnology firm is exploring treatments that regulate the presence of Cortisol, a steroid hormone associated with some psychiatric ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.15 3/31/08 | -0.10 3/31/08 |
0.05
Beat
|
| Last Quarter | -0.10 6/30/08 | -0.09 6/30/08 |
0.01
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 0.00 | 482,000.00 |
| Gross Profit | 0.00 | 469,000.00 |
| Operating Income | -4.69 M | -12.24 M |
| Net Income | -4.40 M | -11.57 M |
Real-Time Quote
